The SOUL protocol had participants randomized 1:1 to oral semaglutide (starting at 3 mg and escalated to 14 mg for the rest of the study) or placebo. Participants were told to take their assigned ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

But the market expects Novo Nordisk to add further billions to its revenue should semaglutide get approved in a daily pill form. The 26-week trial investigated the efficacy and safety of 14 mg ...

Opens in a new tab or window Share on ... adjusted HR 2.08 (95% CI 1.17-3.72) Overall, the incidence rate for hair loss was more than double for semaglutide users than bupropion-naltrexone users ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 inhibitor use, according to data presented at the American College of ...

Researchers conducted a post hoc analysis of the PIONEER trials to compare the efficacy of oral semaglutide versus active comparators in improving T2D cardiometabolic outcomes.